Lantheus Holdings Inc (LNTH)
US$ 98.43-1.34%
Price Chart
Key Statistics
Market Cap
$ 7.11B
P/E Ratio
23.34
Revenue (TTM)
$ 1.53B
Volume
525.54K
52W High
$ 126.89
52W Low
$ 65.76
Dividend Yield
0.00%
Beta
0.20
Technicals
50-Day MA
96.382
200-Day MA
99.0323
52 Week High
126.8899
52 Week Low
65.76
About LNTH
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.
Employees
808
Headquarters
Bedford, MA
CEO
Mr. Brian A. Markison
Latest News
Lantheus Q1 2025 Earnings Call: How to Join the May 7 Investor Presentation - Stock Titan
3 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg